5 June 2016 - ASCO has a PRO committee that is developing and testing PRO measures, which, in the future, may be used to assess quality within ASCO’s Quality Oncology Practice Initiative.

Just a few years ago, few had heard of the term “patient-reported outcome” or “PRO.” Now, PROs seem to come up frequently in discussions about almost every aspect of oncology—in clinical care delivery, clinical trials, quality assessment, and comparative effectiveness research (Fig. 1 shows uses and benefits of PROs in each of these contexts).
PROs are reflections of how patients feel and function—for example, symptoms related to disease or toxicities, physical functioning, or quality of life. They are measured via questionnaires that are rigorously developed and tested to assure that the questions are clear, that they are measuring what we think they are measuring, that they are reliable, and that scores change as we might expect.

For more details, go to: http://am.asco.org/rise-patient-reported-outcomes-oncology?et_cid=37913325&et_rid=977599084&linkid=PRO